A preliminary analysis of antineoplastic activity of parvovirus MVMp NS-1 proteins

Cell Res. 1997 Dec;7(2):217-27. doi: 10.1038/cr.1997.22.

Abstract

Human gastric cancer MKN-45 cells were transfected with pULB 3238, a plasmid carrying MVMp NS-1 gene with its original P4 promoter replaced by the glucocorticoid inducible promoter MMTV-LTR. After the integration and expression of NS-1 gene, some of the transfectants died, while others remained alive, but the growth features of survived cells were changed. For further study on the antineoplastic function of parvoviral NS-1 protein in vivo, transgenic mice carrying NS-1 genes were established by conventional method. Among 4 founders, one of them was found to be able to transmit the transgene to around 50% of their offsprings. RT-PCR was performed to indicate the expression of NS-1 gene in transgenic mice and its mRNA appeared in a variety of tissues. The expression of integrated NS-1 gene may correlate with the decreased incidence of tumor induced in vivo by chemical carcinogens.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents* / pharmacology
  • Cell Division / drug effects
  • Cell Line, Transformed
  • Female
  • Gene Expression Regulation, Viral / drug effects
  • Genes, Viral
  • Growth Inhibitors / physiology
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Neoplasms, Experimental / chemically induced
  • Neoplasms, Experimental / pathology*
  • Neoplasms, Experimental / prevention & control*
  • Transfection
  • Tumor Cells, Cultured
  • Viral Nonstructural Proteins / biosynthesis
  • Viral Nonstructural Proteins / genetics
  • Viral Nonstructural Proteins / physiology*
  • Viral Structural Proteins / genetics

Substances

  • Antineoplastic Agents
  • Growth Inhibitors
  • NS1 protein, minute virus of mice
  • Viral Nonstructural Proteins
  • Viral Structural Proteins